Display options
Cite
Márquez-González H, Méndez-Galván JF, Reyes-López A, et al. Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Front Public Health. 2021;9:660114doi: 10.3389/fpubh.2021.660114.
Márquez-González, H., Méndez-Galván, J. F., Reyes-López, A., Klünder-Klünder, M., Jiménez-Juárez, R., Garduño-Espinosa, J., & Solórzano-Santos, F. (2021). Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Frontiers in public health, 9660114. https://doi.org/10.3389/fpubh.2021.660114
Márquez-González, Horacio, et al. "Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors." Frontiers in public health vol. 9 (2021): 660114. doi: https://doi.org/10.3389/fpubh.2021.660114
Márquez-González H, Méndez-Galván JF, Reyes-López A, Klünder-Klünder M, Jiménez-Juárez R, Garduño-Espinosa J, Solórzano-Santos F. Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Front Public Health. 2021 Jul 27;9:660114. doi: 10.3389/fpubh.2021.660114. eCollection 2021. PMID: 34386471; PMCID: PMC8353107.
Copy Download .nbib Format: NLM
Share it on

Front Public Health. 2021 Jul 27;9:660114. doi: 10.3389/fpubh.2021.660114. eCollection 2021.

Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors.

Frontiers in public health

Horacio Márquez-González, Jorge F Méndez-Galván, Alfonso Reyes-López, Miguel Klünder-Klünder, Rodolfo Jiménez-Juárez, Juan Garduño-Espinosa, Fortino Solórzano-Santos

Affiliations

  1. Department of Clinical Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
  2. Centre for Research in Emerging Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
  3. Centre for Health Economics, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
  4. Research Management, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
  5. Clinical Infectious Disease Department, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
  6. Clinical Research Direction, Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
  7. Infectious Diseases Research Department, Hospital Infantil de México Federico GómezMéxico Federico Gómez, Mexico City, Mexico.

PMID: 34386471 PMCID: PMC8353107 DOI: 10.3389/fpubh.2021.660114

Abstract

The pandemic caused by the new coronavirus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries. The most lethal clinical presentation is respiratory insufficiency, requiring attention in intensive care units (ICU). The most susceptible people are over 60 years old with comorbidities. The health systems organization may represent a transcendental role in survival.

Copyright © 2021 Márquez-González, Méndez-Galván, Reyes-López, Klünder-Klünder, Jiménez-Juárez, Garduño-Espinosa and Solórzano-Santos.

Keywords: COVID-19 outbreak; Mexico; SARS-CoV-2; cohort study; comorbidity; survival analysis

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Infect Public Health. 2021 Apr;14(4):446-453 - PubMed
  2. Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):756-758 - PubMed
  3. Expert Rev Respir Med. 2021 Aug;15(8):973-978 - PubMed
  4. Lancet Child Adolesc Health. 2020 Jul;4(7):e24-e25 - PubMed
  5. JAMA. 2020 May 12;323(18):1775-1776 - PubMed
  6. Crit Care. 2020 Mar 16;24(1):91 - PubMed
  7. Int J Epidemiol. 2021 Jul 9;50(3):732-742 - PubMed
  8. Crit Care. 2021 Feb 16;25(1):68 - PubMed
  9. Infect Dis Poverty. 2021 Feb 3;10(1):11 - PubMed
  10. Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):400-406 - PubMed
  11. Lancet Respir Med. 2021 Apr;9(4):407-418 - PubMed
  12. J Infect Dev Ctries. 2020 Feb 29;14(2):125-128 - PubMed
  13. Pulmonology. 2020 Jul - Aug;26(4):241-244 - PubMed
  14. JAMA. 2020 Mar 17;323(11):1061-1069 - PubMed
  15. BMC Med Res Methodol. 2013 Mar 06;13:33 - PubMed
  16. BMC Public Health. 2020 Oct 27;20(1):1616 - PubMed
  17. Lancet. 2020 Mar 21;395(10228):e52 - PubMed
  18. PLoS One. 2020 Sep 11;15(9):e0238905 - PubMed
  19. Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12575-12578 - PubMed
  20. Ann Hepatol. 2021 Mar-Apr;21:100298 - PubMed
  21. Rev Clin Esp. 2020 Nov;220(8):463-471 - PubMed

MeSH terms

Publication Types